Products
Fees
Download
Promotions
Promotions
Welcome Rewards
Referral Program
US Pre-Market Options Trading
For Institutions
For Institutions
Corporate Services
Developers
Help
About
About
About Longbridge
License & Regulatory
Media Coverage
Join Us
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote List
Quote List
GYBYS
(600332.SH)
Last Updated 00:00:00
News
Financials
Overview
Baiyunshan Q1 Revenue Rises as Profit Margins Narrow and Cash Outflows Ease
Tip Ranks
·
04/27/2026 19:10
SH
600332
-1.40%
HK
00874
-0.86%
Tip Ranks
·
04/27/2026 19:10
SH
600332
-1.40%
HK
00874
-0.86%
"Performance" Baiyunshan's annual net profit is 2.983 billion RMB, an increase of 5.2%, with a final dividend of 0.45 yuan
AASTOCKS
·
03/22/2026 16:53
SH
589720
+1.03%
SZ
159859
-0.55%
SZ
159506
-0.75%
AASTOCKS
·
03/22/2026 16:53
SH
589720
+1.03%
SZ
159859
-0.55%
SZ
159506
-0.75%
With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's "Special Regulations on the Registration of Traditional Chinese Medicine" is entering its final window period. This regulation, referred to in the industry as the "death clause" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibited
Wallstreetcn
·
01/27/2026 18:41
SH
512290
-0.11%
SZ
159929
-0.71%
SH
600436
-0.77%
Wallstreetcn
·
01/27/2026 18:41
SH
512290
-0.11%
SZ
159929
-0.71%
SH
600436
-0.77%
BAIYUNSHAN PH plans to develop an advanced manufacturing center in Hong Kong
AASTOCKS
·
01/09/2026 09:08
SH
600332
-1.40%
HK
00874
-0.86%
AASTOCKS
·
01/09/2026 09:08
SH
600332
-1.40%
HK
00874
-0.86%
BAIYUNSHAN PH fully acquires ZMC distribution company for a consideration of 500 million RMB
AASTOCKS
·
12/17/2025 23:13
SH
600216
-2.12%
SH
600332
-1.40%
HK
00874
-0.86%
AASTOCKS
·
12/17/2025 23:13
SH
600216
-2.12%
SH
600332
-1.40%
HK
00874
-0.86%
Guangyao Group established an animal health technology company with a registered capital of 200 million
Zhitong
·
10/30/2025 14:07
SH
600332
-1.40%
HK
00874
-0.86%
Zhitong
·
10/30/2025 14:07
SH
600332
-1.40%
HK
00874
-0.86%
Understanding the Market | BAIYUNSHAN PH rose over 4% after earnings, with net profit attributable to shareholders for the first three quarters at 3.31 billion yuan; its Wanglaoji International can product has debuted in the Middle East market
Zhitong
·
10/30/2025 10:21
SH
600332
-1.40%
HK
00874
-0.86%
Zhitong
·
10/30/2025 10:21
SH
600332
-1.40%
HK
00874
-0.86%
BAIYUNSHAN PH released its performance for the first three quarters, with a net profit attributable to shareholders of RMB 3.31 billion, an increase of 4.78% year-on-year
Zhitong
·
10/28/2025 18:15
SH
600332
-1.40%
HK
00874
-0.86%
Zhitong
·
10/28/2025 18:15
SH
600332
-1.40%
HK
00874
-0.86%
BAIYUNSHAN PH: Third quarter net profit of 794 million yuan, a year-on-year increase of 30.28%
Zhitong
·
10/28/2025 17:37
SH
600332
-1.40%
HK
00874
-0.86%
Zhitong
·
10/28/2025 17:37
SH
600332
-1.40%
HK
00874
-0.86%